| Literature DB >> 34166554 |
Kenta Takahashi1, Yasunori Sato1, Minako Yamamura1, Satoko Nakada2, Yuko Tamano1, Motoko Sasaki1, Kenichi Harada1.
Abstract
The Notch signaling pathway plays a key role in the morphogenesis of the biliary tree, but its involvement in cystic biliary diseases, such as Caroli disease (CD) and polycystic liver disease (PLD), has yet to be determined. Immunostaining was performed using liver sections of CD and PLD, and the results were compared with those of congenital hepatic fibrosis (CHF) and von Meyenburg complex (VMC). The expression of Notch receptor 1 (Notch1) was increased in the nuclei of biliary epithelial cells in all cases of CD and PLD, whereas it remained at a low level in CHF and VMC. In addition, Notch2 and Notch3 were preferably expressed in the nuclei of biliary epithelial cells of PLD. Accordingly, the Notch effector Hes1 was highly expressed in biliary epithelial cells of CD and PLD, and the cell proliferative activity was significantly higher in CD and PLD. The expression of the Notch ligand Delta-like 1 was significantly increased in biliary epithelial cells of CD and PLD, which may be causally associated with the nuclear overexpression of Notch1 and Hes1. These results indicate that aberrant activation of the Notch-Hes1 signaling pathway may be responsible for the progression of biliary cystogenesis in CD and PLD.Entities:
Keywords: Caroli disease; Hes1; Notch; congenital hepatic fibrosis; polycystic liver disease; therapeutic target; von Meyenburg complex
Mesh:
Substances:
Year: 2021 PMID: 34166554 DOI: 10.1111/pin.13130
Source DB: PubMed Journal: Pathol Int ISSN: 1320-5463 Impact factor: 2.534